title: [Drugs for Alzheimer disease: what will the minister decide].
authors.affiliation: Afdeling Psychiatrie academisch ziekenhuis Maastricht.
authors.forename: F R
authors.initials: FR
authors.lastname: Verhey
authors.forename: P
authors.initials: P
authors.lastname: Scheltens
mesh_terms: D000203:Activities of Daily Living / Q000523:psychology; D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D017277:Drug Approval / Q000331:legislation & jurisprudence; D005260:Female; D006291:Health Policy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D019954:Neurobehavioral Manifestations / Q000187:drug effects; D010830:Physostigmine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012068:Religion and Medicine
chemical_list: D002800:Cholinesterase Inhibitors; C052450:physostigmine heptyl; D010830:Physostigmine